ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer Journal Article


Authors: Li, D.; Zhan, Y.; Wang, N.; Tang, F.; Lee, C. J.; Bayshtok, G.; Moore, A. R.; Wong, E. W. P.; Pachai, M. R.; Xie, Y.; Sher, J.; Zhao, J. L.; Khudoynazarova, M.; Gopalan, A.; Chan, J.; Khurana, E.; Shepherd, P.; Navone, N. M.; Chi, P.; Chen, Y.
Article Title: ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
Abstract: The mechanisms underlying ETS-driven prostate cancer initiation and progression remain poorly understood due to a lack of model systems that recapitulate this phenotype. We generated a genetically engineered mouse with prostate-specific expression of the ETS factor, ETV4, at lower and higher protein dosage through mutation of its degron. Lower-level expression of ETV4 caused mild luminal cell expansion without histologic abnormalities, and higher-level expression of stabilized ETV4 caused prostatic intraepithelial neoplasia (mPIN) with 100% penetrance within 1 week. Tumor progression was limited by p53-mediated senescence and Trp53 deletion cooperated with stabilized ETV4. The neoplastic cells expressed differentiation markers such as Nkx3.1 recapitulating luminal gene expression features of untreated human prostate cancer. Single-cell and bulk RNA sequencing showed that stabilized ETV4 induced a previously unidentified luminal-derived expression cluster with signatures of cell cycle, senescence, and epithelial-to-mesenchymal transition. These data suggest that ETS overexpression alone, at sufficient dosage, can initiate prostate neoplasia.
Keywords: genetics; mouse; animal; metabolism; animals; mice; transcription factor; pathology; protein p53; transcription factors; cell transformation, neoplastic; prostatic neoplasms; gene expression regulation; gene expression regulation, neoplastic; prostate; cell transformation; prostate tumor; tumor suppressor protein p53; prostatic intraepithelial neoplasia; transcription factor ets; proto-oncogene proteins c-ets; humans; human; male; etv4 protein, human
Journal Title: Science Advances
Volume: 9
Issue: 14
ISSN: 2375-2548
Publisher: Amer Assoc Advancement Science  
Date Published: 2023-04-07
Start Page: eadc9446
Language: English
DOI: 10.1126/sciadv.adc9446
PUBMED: 37018402
PROVIDER: scopus
PMCID: PMC10075989
DOI/URL:
Notes: Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF -- MSK corresponding authors are Ping Chi and Yu Chen -- Export Date: 1 May 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yu Chen
    134 Chen
  2. Ping Chi
    175 Chi
  3. Anuradha Gopalan
    418 Gopalan
  4. Yuanyuan Xie
    10 Xie
  5. Wai Pung Elissa Wong
    22 Wong
  6. Joseph Minhow Chan
    48 Chan
  7. Amanda Roxanne Moore
    10 Moore
  8. Jessica   Sher
    13 Sher
  9. Yu   Zhan
    6 Zhan
  10. Dan Li
    17 Li
  11. Jimmy Liu Zhao
    21 Zhao
  12. Cindy J Lee
    19 Lee
  13. Naitao Wang
    8 Wang
  14. Mohini R. Pachai
    8 Pachai